PharmaLex France approved for the Research Tax Credit

PharmaLex France has been approved for the Research Tax Credit for the next 3 years

We are now able to offer our customers a real research tax credit benefit on a yearly basis.

For more information please contact:

Sophie Guillaume
General Manager
PharmaLex France
contact@pharmalex.com

Patrick Larcier
Senior Director, Drug Development & Vigilance
PharmaLex France
contact@pharmalex.com